APLS Short Interest

Apellis Pharmaceuticals, Inc. (APLS) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $5.25B, listed on NASDAQ, employing roughly 705 people, carrying a beta of -0.25 to the broader market. Apellis Pharmaceuticals, Inc. Led by Cedric Francois, public since 2017-11-09.

Short interest is the total number of shares currently sold short and not yet covered, reported bi-monthly by FINRA. Days to cover (short interest divided by average daily volume) indicates how long it would take short sellers to close positions, with higher values signaling greater squeeze potential.

Settlement Date

2026-04-30

Short Interest

10.8M

Previous Short Interest

14.2M

Change

-24.48%

Days to Cover

3.06

Avg Daily Volume

3.5M

Avg Days to Cover (24 reports)

7.91

Showing 24 bi-monthly FINRA short interest reports for Apellis Pharmaceuticals, Inc..

Learn how short interest is reported and how to read the data →